L250-1102 Screening compound: 2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]-N-[(pyridin-3-yl)methyl]propanamide

L250-1102 Screening compound: 2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]-N-[(pyridin-3-yl)methyl]propanamide
L250-1102 Screening compound: 2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]-N-[(pyridin-3-yl)methyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L250-1102
2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]-N-[(pyridin-3-yl)methyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L250-1102

Molecular Formula

C28H28N4O3 (C28 H28 N4 O3)

Compound Name

2-[1-(2-phenyl-1,3-benzoxazole-6-carbonyl)piperidin-4-yl]-N-[(pyridin-3-yl)methyl]propanamide

IUPAC name

2-[1-(2-phenyl-13-benzoxazole-6-carbonyl)piperidin-4-yl]-N-[(pyridin-3-yl)methyl]propanamide

SMILES

CC(C(CC1)CCN1C(c(cc1)cc2c1nc(-c1ccccc1)o2)=O)C(NCc1cnccc1)=O

InChI

InChI=1S/C28H28N4O3/c1-19(26(33)30-18-20-6-5-13-29-17-20)21-11-14-32(15-12-21)28(34)23-9-10-24-25(16-23)35-27(31-24)22-7-3-2-4-8-22/h2-10,13,16-17,19,21H,11-12,14-15,18H2,1H3,(H,30,33)/t19-/m0/s1

InChI Key

IISDJLXIQDLXRK-IBGZPJMESA-N

MDL Number (MFCD)

MFCD15120953

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.861

Distribution Coefficient, logD

2.859

Water Solubility, LogSw

-3.20

Polar Surface Area

67.628

Acid Dissociation Constant (pKa)

13.36

Base Dissociation Constant (pKb)

5.15

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.60

L250-1102 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

CNS Targets (44014 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Nervous system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L250-1102 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L250-1102?
Check Price and Availability of L250-1102, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L250-1102 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L250-1102
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L250-1102
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L250-1102 available by request